Personalized Treatment System Synchronizing Bioactive Agents and Sensory Experiences
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively combine bioactive agents with artificial sensory experiences based on pharmacokinetic or pharmacodynamic profiles and administration schedules, limiting personalized treatment approaches.
Innovation Solution
A system and method that accept indications of bioactive agent schedules and profiles, and present artificial sensory experiences accordingly, using circuitry and programming to integrate these elements for personalized treatment delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If bioactive agents are administered according to fixed schedules without integration of pharmacokinetic or pharmacodynamic profiles, then treatment protocols are simple to implement, but treatment personalization and efficacy are limited
Solution Approach 1:
The patent combines multiple data elements (pharmacokinetic profiles, pharmacodynamic profiles, administration schedules, and sensory experience parameters) into a unified treatment plan. The system merges these previously separate components into an integrated personalized treatment approach, allowing the treatment protocol to adapt to individual patient characteristics while maintaining systematic organization through the computing device.
Solution Approach 2:
The system transforms static fixed schedules into dynamic treatment protocols that adjust based on real-time pharmacokinetic and pharmacodynamic profiles. The administration schedule and sensory experience parameters are no longer fixed but are dynamically modified according to measured patient responses and biological profiles, enabling continuous optimization of treatment personalization.
2Reliability
If bioactive agent administration is combined with artificial sensory experiences based on pharmacokinetic/pharmacodynamic profiles, then treatment efficacy is enhanced, but implementation complexity increases
Solution Approach 1:
The computing device serves as an intermediary that processes complex pharmacokinetic and pharmacodynamic data and translates it into coordinated control signals for both bioactive agent delivery and artificial sensory experience generation. This intermediary system manages the complexity by automating the integration logic, allowing the combination of multiple treatment modalities while maintaining manageable system architecture.
Solution Approach 2:
The system creates a multi-functional platform that simultaneously handles pharmacokinetic analysis, pharmacodynamic monitoring, administration scheduling, and sensory experience coordination. By designing a universal system that performs multiple functions through integrated circuitry and programming, the patent reduces the need for separate independent systems, thereby managing overall complexity while achieving enhanced treatment efficacy.
3Ease of operation
If personalized treatment plans synchronize bioactive agent administration with artificial sensory experiences, then patient comfort and efficacy improve, but data processing requirements increase
Solution Approach 1:
The system performs preliminary processing of pharmacokinetic and pharmacodynamic profiles before actual treatment delivery. By pre-calculating optimal administration schedules and corresponding sensory experience parameters based on patient profiles, the system reduces real-time data processing requirements during treatment delivery. This preliminary action ensures patient comfort through personalized synchronization while managing data processing load through advance computation.
Data Source
AI summary
Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of a bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.